stella
beta
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. — Stella
Recruiting
Back to Thyroid Associated Ophthalmopathies trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(2 sites)
China
Shanghai Changzheng Hospital, Changhua, Shanghai Municipality
Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov